Prostate Cancer

Prostate Cancer CTC PSMA Status Could Guide Therapy

By

John Schieszer, MA

Publish Date October 5, 2022

PSMA expression on circulating tumor cells in men with mCRPC increases upon disease progression despite treatment with novel antiandrogens.

Novel Hormonal Therapies for nmCRPC Underused, Data Show

By

Jody A. Charnow

Publish Date September 30, 2022

Investigators characterized practice patterns in the first-line treatment of nonmetastatic castration-resistant prostate cancer using real-world data.

PRESTO: ADT Intensification Prolongs PSA PFS in Biochemically Recurrent Prostate Cancer

By

Jessica Nye, PhD

Publish Date September 29, 2022

Phase 3 results appear to support intensification of ADT in patients with biochemically recurrent prostate cancer.

Coffee Intake Linked to Longer Prostate Cancer-Specific Survival

Publish Date September 28, 2022

Longer prostate cancer-specific survival seen for specific subgroups, including those with the CYP1A2 AA genotype.

Prostate Cancer Survivors Weigh In on Visual Timelines of Patient-Reported Outcomes

By

Jennifer Larson

Publish Date September 27, 2022

Of 4 prototypes assessed, participants preferred meter as having the best gist comprehension and emoji as having the highest verbatim comprehension.

Prostate Cancer Resources

Clinical Trials

Drug Monographs

Fact Sheets